News Article
North Hollywood, CA, June 1, 2017—The International Myeloma Foundation (IMF) today announced that Paul G. Richardson, MD, the R.J. Corman Professor of Medicine at Harvard Medical School and Clinical Program Leader / Director of Clinical Research at the Jerome Lipper…
Videos
click on the image above to watch the teleconference
(to view the teleconference in fullscreen, click on the bottom right square icon beside the YouTube logo)
Watch the replay of the “Living Well with Myeloma” teleconference followed by a 15-minute Q&A from callers. The topic…
News Article
NORTH HOLLYWOOD, CA – The International Myeloma Foundation (IMF) expressed its deep concerns with the American Health Care Act (AHCA), which narrowly passed the U.S. House of Representatives today. Multiple myeloma is the second most common blood cancer. Despite the advances in treating this…
News Article
Republican and Democratic Congressional leaders reached a government funding compromise deal on Sunday evening. We are happy to report this compromise includes $2 billion in new NIH funds, despite fears the agency would receive cuts. Specifically, the bill provides for an additional $476 million to…
Audio
David Waits woke up early at 4:30 a.m. to begin his work day with the hopes of being able to get to an afternoon golf tournament. However, that afternoon, he experienced extreme back pain and decided to sit out of golfing. Unable to see his usual general practitioner, he went to the ER. It was…
Audio
Deb Lacey visited an endocrinologist for another health issue, and after undergoing a number of tests at this doctor, she learned that she not only had thyroid cancer, but a high-level of protein in her blood. She soon had her thyroid removed, and then followed-up about the blood protein at Moffatt…
Audio
In December 2014, Bob Nist developed a rash on his chest. After it did not go away, the dermatologist sent Bob to an oncologist, and Bob was diagnosed with smoldering myeloma. After emailing his college classmate who connected Bob to Dr. Paul Richardson at Dana Farber Cancer Institute, Bob…
Videos
In this week’s video, Dr. Brian G.M. Durie explains how certain variations in genes…
Audio
As a Nurse Practitioner, Julia Pallentino felt that her recurrent back pain was no cause for alarm. In 2011, a couple months before a planned vacation, the pain began to get worse and her chiropractor demanded she see an orthopedist. A large plasmacytoma was discovered on her spine, yet she had no…
Audio
Guy Ratzlaf was getting ready to go work one Friday morning, and he couldn’t turn the steering wheel in his car. Immediately, he and his wife went to the ER. Before he even knew much about myeloma, he began his initial treatment. Guy participated in a clinical trial, in which he took thalidomide…
Audio
One morning Joe Petty suffered from excruciating back pain in the shower, and his wife Patricia called an ambulance to take him to Mayo Clinic Jacksonville. It was there he learned he had multiple myeloma. Familiar with the disease because he had lost a first cousin to myeloma, Joe was still…
Videos
In this week’s video, Dr. Brian G.M. Durie explains some the different causes of lung infections and how to possibly treat each kind.
BOTTOM LINE:
Discuss with your doctor how to treat recurrent lung infections.
Audio
In 2014, after having severe pain in her chest and upper back, Camille Wilson learned she had two crushed vertebrae and was shortly thereafter diagnosed with myeloma. Today Camille continues on Revlimid maintenance and maintains hope by taking part in meetings with the North Tampa Multiple Myeloma…
News Article
View This Webinar on Co-Pay Assistance Here.
Recently, the International Myeloma Foundation’s InfoLine has been flooded with calls from patients and caregivers facing insurmountable financial challenges due to the high cost of…
Videos
In this week’s video, Dr. Brian G.M. Durie answers a patient’s concern about when and if to undergo an ASCT.
BOTTOM LINE:
Talk to your doctors about all the risks versus benefits of an ASCT in your case.
News Article
Myeloma Action Network (GMAN), a group of patient organizations in five continents, has declared Thursday, March 30 as International Myeloma Action Day to raise awareness of the disease, to advocate for early detection of multiple myeloma, to ensure treatment options are available worldwide, and to…
News Article
Many aspects of the recent budget proposal may impact cancer research. The most concerning cuts would occur within the National Institutes of Health (NIH), which would cut approximately 20% — or $6 billion — of their current budget. These cuts would completely negate the benefits from last year's…
News Article
View the Novel Agents and Clinical Trials Teleconference Now
Dr. Craig Cole (University of Michigan Comprehensive Cancer Center) gives an update on the novel agents currently used to treat multiple myeloma and…
Videos
click on the image above to watch the webinar(to view the teleconference in fullscreen, click on the bottom right square icon beside the YouTube logo)Recently, the International Myeloma Foundation’s InfoLine has been flooded with calls from patients and caregivers facing…
News Article
In the latest episode of “Vital Signs,” CNN Chief Medical Correspondent Dr. Sanjay Gupta travels to Iceland, where he interviews International Myeloma Foundation Chairman Dr. Brian Durie and Principal Investigator Dr. Sigurdur Kristinsson about the Black Swan Research Initiative®…
Videos
CNN's Sanjay Gupta "Vital Signs" Interview on the IMF's iStopMM Project
In the latest episode of “Vital Signs,” CNN Chief Medical Correspondent Dr. Sanjay Gupta travels to Iceland, where he interviews International Myeloma Foundation Chairman Dr. Brian Durie and Principal Investigator…
Videos
In this week’s video, Dr. Brian G.M. Durie explores the complications that can occur during the MGUS and smoldering myeloma stages of disease.
BOTTOM LINE:
Discuss any complications with your doctor, such as a low white blood cell count…
News Article
To help raise awareness of multiple myeloma during Myeloma Action Month, Amgen is partnering with the IMF to execute a social media Thunderclap! We’re asking myeloma patients, health care professionals, advocates, caregivers and family or friends of those impacted with this disease to visit the…
Videos
In this video, Dr. Brian G.M. Durie explains why kappa and lambda levels typically decrease for myeloma patients.
BOTTOM LINE:
While lambda and kappa levels may lower, it’s usually not concerning.
Videos
In this video, Dr. Brian G.M. Durie explains how holes in the bone may partially heal, but these holes do not fully recover.
BOTTOM LINE:
Be examined for lytic lesions by your doctor and intervene as necessary.
News Article
Q. I make a point of reading myeloma-related articles in medical journals, but I have a hard time understanding statistics. Can you help me interpret this information?
A. In the Summer 2016 edition of Myeloma Today, the InfoLine column was dedicated to the art…
News Article
The 21st Century Cures, a wide-ranging bill that authorizes additional cancer research funding as well as funds for the US Food and Drug Administration (FDA) to streamline drug and device approval processes, passed the Senate on December 7 with a bipartisan backing of 94–5 and was signed into law…
News Article
On December 3rd, the IMF awarded its 2017 Brian D. Novis Research Grants. The grant presentation ceremony was held during the 58th annual meeting of the American Society of Hematology (ASH) in San Diego, California.
For 22 years, the IMF has funded the most promising research in the field of…
News Article
New Insights on Improving Myeloma Patient Outcomes with Triple Therapy
LOS ANGELES, Dec. 23, 2016 -- The International Myeloma Foundation (IMF) today announced the publication in The Lancet of the results of a randomized, phase III trial, conducted by SWOG, a publicly…
Videos
In this week’s video, Dr. Brian G.M. Durie provides results of the StaMINA trial.
BOTTOM LINE:
Tandem transplants and consolidation are no longer routinely required.
News Article
Hematology Conference in San Diego Draws Researchers, Physicians, Healthcare Professionals, Patient Advocates
North Hollywood, CA, December 1, 2016 – The International Myeloma Foundation (IMF) – improving the quality of life of myeloma…
News Article
FDA Approval of Darzalex in Early Relapse Setting a Game Changer
On November 21st, Darzalex® (daratumumab) was approved by the U.S. Food and Drug Administration in combination with lenalidomide/dexamethasone or…
Videos
In this week’s video, Dr. Brian G.M. Durie explains which precautions myeloma patients should take before electing to have surgery.
BOTTOM LINE:
Go ahead and undergo necessary surgeries but use precautions.
Treatment Advances in Multiple Myeloma: Expert Perspectives on Translating Clinical Data to Practice
Videos
Join us for a provocative program that includes interactive case discussions and a review of the data from a panel of renowned myeloma experts who will provide varied perspectives on new data, guideline changes, and expert recommendations for management of patients with multiple myeloma.…
News Article
>NORTH HOLLYWOOD, Calif., Nov. 18, 2016 /PRNewswire/ -- The International Myeloma Foundation (IMF) congratulates seventy-five-year-old Don Wright on approaching his 100th marathon since being diagnosed with multiple myeloma in 2003. When Don first learned he had myeloma,…
News Article
North Hollywood, CA, November 10, 2016 – For the second straight season, every three-point basket made by players of the 17-time champion Boston Celtics will trigger a donation to the International Myeloma Foundation (IMF), courtesy of Takeda and its “3 Points for Patients”…
Videos
In this video, Dr. Brian G.M. Durie explains why different tests may have conflicting results for the level of myeloma protein in a patient's body.
BOTTOM LINE:
Test and re-test to clarify conflicts in test results.
News Article
Founder and President of the International Myeloma Foundation Susie Novis Durie and the organization’s Chairman of the Board Dr. Brian Durie launched the 10th Annual Comedy Celebration at the Wilshire Ebell Theatre in Los Angeles, on Saturday, November 5, 2016. Since the inception of the event 10…
News Article
Los Angeles, CA—November 2, 2016—The International Myeloma Foundation (IMF) – improving the quality of life of myeloma patients while working toward prevention and a cure – is pleased to announce that the National Comprehensive Cancer Network (NCCN) has revised its clinical…
News Article
On July 27, 2016, the new response criteria from the IMF’s International Myeloma Working Group (IMWG) incorporating minimal residual disease (MRD) testing was published in The Lancet Oncology. Achieving consensus by more than 200 of the world’s top myeloma researchers on these criteria…
News Article
A member of the IMF’s Nurse Leadership Board since its inception, Joseph Tariman, PhD, ANP-BC, is Assistant Professor in the School of Nursing/College of Science and Health at DePaul University in Chicago, Illinois. The IMF congratulates Dr. Tariman on his most recent distinction:…
Videos
In this video, Dr. Brian G.M. Durie discusses if myeloma proteins that leak out into the tissues impact the protein level in the blood.
BOTTOM LINE:
Be patient when considering myeloma protein levels. …
Videos
In this week’s video, Dr. Brian G.M. Durie addresses a myeloma patient’s concerns about having femoropopliteal bypass graft surgery.
BOTTOM LINE:
Surgery for a myeloma patient should be approached in the same fashion as it would be for any other…
News Article
North Hollywood, California, September 15, 2016 —The International Myeloma Foundation (IMF) – the largest and oldest organization dedicated to improving the lives of myeloma patients while working toward prevention and a cure – is excited to announce John Taussig has completed his…
Audio
Dan List was diagnosed with myeloma in 2005. He was told he could expect to live two to five years. He decided he would fight the disease with a positive attitude because a negative attitude was not an option.
News Article
The International Myeloma Foundation held its fifth Master Class from August 15–20, 2016. This prestigious advanced training course is offered annually to leading young Chinese hematologists, selected for participation by the Chinese Myeloma Committee. The course is hosted by the IMF in Los Angeles…
Videos
In this week’s video, Dr. Brian G.M. Durie addresses a concerned patient’s question…
News Article
Close to one hundred members of the International Myeloma Working Group (IMWG) gathered in Copenhagen from June 7th to 9th, just prior to the European Hematology Association (EHA) meeting, for the seventh annual IMWG Summit. This important and prestigious meeting allows myeloma experts from around…
Videos
In this week’s video, Dr. Brian G.M. Durie addresses a patient’s concerns about different recommendations she has received about monitoring her disease.
BOTTOM LINE:
Patients in remission must have their myeloma monitored regularly and see their GP…
News Article
The myeloma community is at a critical moment in its history. While we are pleased that four new myeloma drugs (Darzalex®, Empliciti®, Ninlaro®, and Farydak®) were approved in 2015 by the US Food and Drug Administration, the annual price tag for some treatment combinations can climb well above six…